In particular, in neuroblastoma, the MYCN oncogene positively regulates and maintains the expression of RNA isoforms with high ORF dominance, and the expression of high ORF dominance transcripts in neuroblastoma is associated with poor patient prognosis [23]. The gene discussed is MYCN; the disease is neuroblastoma.